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The  renin–angiotensin  system  is  an  important  link  between  metabolic  syndrome  and  cardiovascular
diseases.  Besides  angiotensin  II, other  angiotensin  peptides  such  as  angiotensin-(1–7),  have important
biological  activities.  It has  been  demonstrated  that  angiotensin-(1–7),  acting  through  the  G  protein-
coupled  receptor  encoded  by the  Mas  protooncogene  have  important  actions  on  the  cardiovascular
system.  However,  the role  of angiotensin-(1–7)-Mas  axis  in  lipidic  proﬁle  is not  well  established.  In
the  present  study,  the  adipocyte  metabolism  was  investigated  in  wild  type  and FVB/N  Mas-deﬁcient
male  mice.  The  gene  expression  of  peroxisome  proliferator-activated  receptor  gamma,  acetyl-CoA  car-
boxylase  and  the  amount  of  fatty  acid  synthase  protein  were  reduced  in  the  Mas-knockout  mice.  Serum
nonesteriﬁed  fatty  acids  of  Mas-knockout  showed  a  50%  increase  in  relation  to wild  type  group.  Basal
and  isoproterenol-stimulated  lipolysis  was  similar  between  the  groups,  however,  a signiﬁcant  decrease
of  the  glycerol  release  (lipolytic  index)  in  response  to  insulin  was observed  in  wild  type  animals,  while
no effect  of the  insulin  action  was  observed  in  a  Mas-knockout  group.  The  data suggest  that  the lack  of
angiotensin-(1–7)  action  through  Mas  receptor  alters  the response  of  adipocytes  to  insulin  action.  These
effects  might  be related  to  decreased  expression  of PPAR.
©  2011  Elsevier  Inc.  Open access under the Elsevier OA license.. Introduction
Adipose tissue plays a central role in the management of sys-
emic energy stores, in part due to its capacity to accumulate
riacylglycerols, but is also a function of its ability to secrete many
roteins that have a major impact on energy homeostasis [17]. A
ysregulation of both process leads to profound changes in insulin
ensitivity at the level of whole organism.
Recently, considerable attention has been given to the role of
he renin–angiotensin system (RAS) in the metabolic syndrome
nd cardiovascular disease, and studies have shown that RAS com-
onents, especially angiotensinogen found in adipose tissue, are
elated to the angiotensin II (Ang II) effects on insulin resistance
5,13,25]. It is also reported that the activation of peroxisome
roliferator-activated receptor gamma  (PPAR)  or a PPAR agonist
∗ Corresponding author at: Departamento de Fisiologia e Biofísica, Instituto de
iências Biológicas/UFMG, Av. Antônio Carlos, 6627, 31270-901 Belo Horizonte, MG,
razil. Tel.: +55 031 3409 2944; fax: +55 031 3409 2924.
E-mail address: botion@icb.ufmg.br (L.M. Botion).
196-9781/© 2011 Elsevier Inc. 
oi:10.1016/j.peptides.2011.11.014
Open access under the Elsevier OA license.such as thiazolidines, induces adipocyte differentiation and a
smaller size of adipocytes, and improves insulin resistance
[2,8,26].
Besides Ang II, other angiotensin peptides such as angiotensin-
(Ang)-(1–7), have important biological activities. Ang-(1–7) is
formed primarily from Ang II by angiotensin-converting enzyme 2
(ACE2) and from Ang I by prolylendopeptidase or neutral endopep-
tidase and, indirectly and to a lesser extent, by ACE2 [7,18,20,23].
It has been demonstrated that angiotensin-(1–7), acting through
the G protein-coupled receptor encoded by the Mas  protoonco-
gene prevents diabetes-induced cardiovascular dysfunction [3] and
reverses insulin resistance induced by a high-fructose diet [14]. Pre-
vious studies demonstrated that absence of Mas  receptor leads to
changes in glycemic and lipid metabolism, inducing a metabolic
syndrome-like state [25]. On the other hand, chronic elevation of
plasma Ang-(1–7) levels improves insulin sensitivity, glucose toler-
ance and increased glucose uptake by adipocytes [24]. However, the
role of Ang-(1–7)/Mas axis in lipidic metabolism of adipose tissue
is not well established. The aim of the present study was evaluate
the effect of Mas  deﬁciency on the adiposity markers of adipose
tissue.
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pig. 1. Effect of genetic deletion of the Mas  receptor in epididymal adipose tissue mR
f  PPAR. (B) Expression of ACC. (C) Amount of FAS protein. (n = 6); *p < 0.05 vs. WT
. Materials and methods
.1. Animals
FVB/N Mas-knockout (Mas-KO) and FVB/N wild-type (WT) mice,
ged 8–10 weeks, were obtained from the transgenic animal facil-
ties at Laboratory of Hypertension (Federal University of Minas
erais, Belo Horizonte, Brazil) and kept under controlled light
nd temperature conditions, with free access to water and stan-
ard diet. The animals were maintained according to the ethical
uidelines of our institution, and the experimental protocol was
pproved by the Ethical Committee in Animals Experimentation of
he Federal University of Minas Gerais (Protocol 147/2008).
.2. Serum NEFA and adipose tissue protein determination
The serum was obtained after centrifugation (3500 rpm for
5 min  at 4 ◦C), and the level of non-esteriﬁed fatty acids (NEFA)
as measured using enzymatic kit (Randox Life Science Ltd., USA).
rotein extracted from epididymal adipose tissue was quantiﬁed
y the method of Bradford [6].
.3. Adipose isolation and lipolysis assay
Adipocytes were isolated from epididymal fat pads by the
ethod of Rodbell [22]. Digestion was carried out at 37 ◦C with con-
tant shaking for 45 min. Cells were ﬁltered through nylon mesh
nd washed three times with buffer containing (mM):  137 NaCl,
 KCl, 4.2 NaHCO3, 1.3 CaCl2, 0.5 MgCl2, 0.5 MgSO4, 0.5 KH2PO4,
0 mM HEPES (pH 7.4), plus 1% BSA.
Glycerol release was measured and used as lipolytic index,
s previously described [11]. After isolation, adipocytes were
ncubated at 37 ◦C in a water bath for 60 min, in basal con-
itions or in the presence of 0.1 M isoproterenol (ISO), a
on-speciﬁc beta-receptor agonist. The effects of 25 ng/mL insulin
n isoproterenol-stimulated lipolysis were also determined.
.4. Reverse transcription and real-time PCR
Total RNA from adipose tissue was prepared using Tri-
hasis reagent (BioAgency, São Paulo, SP, Brazil), treated with
NAse. Strand cDNA was generated from 2 g of RNA using
-MuLV Reverse Transcriptase (Fermentas, Thermo Fisher
cientiﬁc Inc., USA). The hypoxanthine guanine phospho-
ibosyltransferase (HPRT-endogenous control), peroxisome
roliferator-activated receptor gamma  (PPAR)  and acetyl-CoA
arboxylase (ACC) cDNA were ampliﬁed using speciﬁc primers
nd SYBER green reagent (Applied Biosystems) in an ABI Prism
000 platform (Applied Biosystems). The following primer
airs were used: HPRT reverse 5′-gattcaacttgcgctcatcttaggc-3′;pression performed by real-time PCR and Western blotting analyses. (A) Expression
.
HPRT forward 5′-gttggatacaggccagactttgtt-3′; PPAR reverse 5′-
aggaactccctggtcatgaatcct-3′; PPAR forward
5′-agatcatctacaccatgctggcct-3′; ACC reverse 5′-
aatccactcgaagaccactg-3′; ACC forward 5′-cggcttgcacctagtaaaac-3′.
2.5. Western blotting analysis
Protein was extracted from epididymal adipose tissue and 30 g
of protein were resolved on SDS-PAGE (10%) and then transferred
onto nitrocellulose membranes. For immunoblotting, the mem-
branes were probed with a polyclonal rabbit anti-FAS antibody
(1:1000; Abcam Inc., USA). The blots were then incubated with
HRP-conjugated anti-rabbit IgG (1:1000; Sigma-Aldrich) and -
actin was  used as endogenous control. The protein abundance was
detected by chemiluminescence (Immobilon Western, Millipore
Corporation) and immuno-reactive bands were visualized by den-
sitometry using an Image J program, National Institute of Health,
USA. The results were expressed by the relationship FAS/-actin in
units of relative density.
2.6. Statistical analysis
The data are reported as mean ± SEM. Differences between
groups were evaluated using unpaired Student’s test. To analyze
lipolytic activity analysis of variance (ANOVA) was  used, followed
by Newman–Keuls test. Signiﬁcance level was set at p < 0.05.
3. Results
The absence of Mas  receptor induced 60% decrease in the
gene expression of PPAR (WT  = 1.6 ± 0.13 arbitrary unit vs. Mas-
KO = 0.65 ± 0.08 arbitrary unit, p < 0.05) and a 51% decrease in the
gene expression of ACC (WT  = 1.5 ± 0.031 arbitrary unit vs. Mas-
KO = 0.73 ± 0.012 arbitrary unit, p < 0.05) (Fig. 1A and B).
The results also showed a decrease in FAS content of Mas-KO
animals in relation to WT  group (WT  = 0.9 ± 0.043 arbitrary unit vs.
Mas-KO = 0.69 ± 0.019 arbitrary unit, p < 0.05) (Fig. 1C).
The genetic deletion of Mas  receptor induced an increase
of 50% in serum NEFA (WT  = 1.2 ± 0.07 mmol vs. Mas-
KO = 1.8 ± 0.24 mmol, p < 0.05) as compared with wild-type animals
(Fig. 2A). The basal lipolysis was  similar between the groups
(WT = 0.61 ± 0.09 mM vs. Mas-KO = 0.58 ± 0.07 mM,  Fig. 2B), how-
ever, the isoproterenol-stimulated lipolysis increased ∼240% in
wild-type animals (basal = 0.61 ± 0.09 mM vs. ISO = 2.10 ± 0.17 mM,
p < 0.05) and ∼205% in Mas-KO animals (basal = 0.58 ± 0.07 mM
vs. ISO = 1.77 ± 0.1 mM,  p < 0.05) over basal condition (Fig. 2B). A
signiﬁcant decrease (41%) of the glycerol release in response to
insulin was observed in the WT  group (ISO = 2.1 ± 0.17 mM vs.
ISO + INS = 1.24 ± 0.17 mM,  p < 0.05), however, the ability of insulin
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Fig. 2. Effect of genetic deletion of the Mas  receptor in plasma NEFA (A) and adipose tissue lipolytic activity epididymal (B). In lipolytic activity the adipocytes were incubated
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s.  WT or compared with basal in (B); †p < 0.05 vs. iso; ‡p < 0.05 vs. ISO + INS, WT gro
o inhibit lipolysis was blunted in the KO group (ISO = 1.77 ± 0.1 mM
s. ISO + Ins = 1.7 ± 0.1 mM,  Fig. 2B).
. Discussion
In the present study, we demonstrated that the expression of
ranscription factor PPAR was decreased in mice with deletion
f the G protein-coupled receptor Mas. PPAR is involved in the
egulation of insulin sensitivity [8] and is a key regulator of fatty
cid uptake and lipogenesis through its inﬂuence on the produc-
ion of enzymes required for lipid storage and metabolism [16].
he activation of PPAR by TZDs (thiazolidinediones) regulates the
ipid metabolism with reduction of NEFA and the up-regulation of
ey genes involved in lipogenesis and triglyceride storage in adi-
ose tissue [4]. Recent reports indicated that some AT1 receptor
Ang II receptor) blockers show an agonistic action on a PPAR
2,15,27]. In addition, studies from Dhaunsi et al. [9] indicated that
ng-(1–7)-mediated signaling could be an effective way  to pre-
ent the elevation of NADPH oxidases activity and inhibition of
PAR in streptozotocin-induced diabetes in normal and hyper-
ensive rats. These studies indicate that the absence of activation of
he Ang-(1–7)/Mas receptor/axis induces a decrease in expression
f PPAR.
The results also show that Mas  receptor deﬁciency alters the
esponse of adipocytes to insulin action evidenced by decreased
xpression of lipogenic enzymes in adipose tissue.
This study is the ﬁrst to report that the absence of the Mas  recep-
or causes a decrease in gene expression of PPAR in adipose tissue
hat is accompanied by a lower gene expression of acetyl-CoA car-
oxylase (ACC) and lower amounts of protein fatty acid synthase
FAS), the target enzymes PPAR. The treatment of adipocytes in
rimary culture with Ang-(1–7) increased adiponectin production
nd this effect was blocked by antagonist of Mas  receptor. Together,
hese results demonstrated the importance of a functionally active
ng-(1–7)-Mas axis in the adipocyte metabolism.
The results of this study also demonstrated important dif-
erences in the responsiveness of adipocytes to insulin in
as-deﬁcient mice. The lack of Ang-(1–7) action through Mas
eceptor increased levels of serum NEFA and decreased the
esponse of adipocytes to the antilipolytic effect of insulin. In
at cells, insulin inhibits the mobilization of NEFA by decreas-
ng the rate of lipolysis and/or increasing the lipogenic rate
nd lipid storage. Insulin resistance in adipose tissue is charac-
erized by decreased suppression of adipose tissue lipolysis by
nsulin, resulting in elevated circulating NEFA levels [19]. Increasedrenol plus 25 ng/ml of insulin. Values are expressed as mean ± SEM. (n = 6); *p < 0.05
NEFA concentrations leads to serine/threonine phosphorylation of
insulin receptor substrate (IRS-1 and IRS-2), subsequently reducing
the ability of the IRS to activate phosphatidylinositol (PI) 3-kinase
and glucose transport [28]. Recently Giani et al. [14] demonstrated
that infusion of Ang-(1–7) in rats resulted in a reversal of fructose-
induced insulin resistance through the IR/IRS/PI3 K/Akt pathway in
the main target of insulin: skeletal muscle, liver and adipose tissue.
These ﬁndings are in accordance with the observation that trans-
genic rats, with chronic elevation of plasma Ang-(1–7), improved
responsiveness to insulin stimulation and increased total and phos-
phorylated Akt in adipose tissue [24]. In addition, previous work
from our group have shown that Mas-knockout mice presented
glucose intolerance and reduced insulin sensitivity as well as a
decrease in insulin-stimulated glucose uptake by adipocytes and
decreased GLUT4 in adipose tissue [25].
Previous studies have shown that Mas-deﬁcient mice present
lack of several Ang-(1–7) actions, mainly concerning to behavior
and cardiovascular regulation [1]. Mas  receptor deletion abolished
the vasodialator effect of Ang-(1–7) in vitro and also induced a
hypertensive state in FVB/N mice. All these data are followed by
dysbalance between nitric oxide and reactive oxygen species in
the vessel wall of Mas-KO. Recently studies have shown that Mas
knockout mice presented a prothrombotic proﬁle [12], altered
calcium signaling on cardiomyocytes [10] and renal dysfunction
[21].
In conclusion, the absence of Ang-(1–7)/Mas axis induces impor-
tant alterations in adipose tissue, evidenciated by decreased insulin
sensibility in adipocytes, which might be consequent to: (1)
decreased mRNA expression of PPAR; (2) exacerbation of Ang-II
action as a consequence of the missing contraregulation by Ang-
(1–7), via receptor Mas.
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